Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Shares Outstanding (Weighted Average) (2020 - 2023)

Historic Shares Outstanding (Weighted Average) for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $42.7 million.

  • Cullinan Therapeutics' Shares Outstanding (Weighted Average) fell 630.77% to $42.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $42.7 million, marking a year-over-year decrease of 630.77%. This contributed to the annual value of $45.2 million for FY2022, which is 484.48% up from last year.
  • Latest data reveals that Cullinan Therapeutics reported Shares Outstanding (Weighted Average) of $42.7 million as of Q3 2023, which was down 630.77% from $40.3 million recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Shares Outstanding (Weighted Average) registered a high of $45.6 million during Q3 2022, and its lowest value of $18.7 million during Q1 2020.
  • For the 4-year period, Cullinan Therapeutics' Shares Outstanding (Weighted Average) averaged around $36.9 million, with its median value being $42.7 million (2023).
  • As far as peak fluctuations go, Cullinan Therapeutics' Shares Outstanding (Weighted Average) soared by 12391.49% in 2021, and later crashed by 1015.76% in 2023.
  • Over the past 4 years, Cullinan Therapeutics' Shares Outstanding (Weighted Average) (Quarter) stood at $19.9 million in 2020, then soared by 116.61% to $43.1 million in 2021, then increased by 4.84% to $45.2 million in 2022, then dropped by 5.38% to $42.7 million in 2023.
  • Its last three reported values are $42.7 million in Q3 2023, $40.3 million for Q2 2023, and $40.7 million during Q1 2023.